Participant selection for lung cancer screening by risk modelling (the Pan-Canadian Early Detection of Lung Cancer [PanCan] study): a single-arm, prospective study
Martin C. Tammemägi(Brock University), Stephen Lam(University of British Columbia), Glenwood Goss(Ottawa Hospital), Natasha B. Leighl(Princess Margaret Cancer Centre), John C. English(University of British Columbia Hospital), Lori Stewart(Juravinski Hospital), Francis Laberge(Ontario Institute for Cancer Research), Annette McWilliams, Kayvan Amjadi(Ottawa Hospital), William K. Evans(NHS Forth Valley), Jean‐Claude Cutz(BC Cancer Agency), Christian Couture(Institut universitaire de cardiologie et de pneumologie de Québec), Serge Puksa(Juravinski Hospital), Don D. Sin(University of British Columbia), Paul Burrowes(University of Calgary), Kazuhiro Yasufuku(University Health Network), John R. Goffin(Juravinski Hospital), Alain Tremblay(Alberta Health Services), Simon Martel(Université du Québec), Jean M. Seely(Ottawa Hospital), Harmanjatinder S. Sekhon(Ottawa Hospital), Daria Manos(Dalhousie University), Paola V. Nasute Fauerbach(Queen's University), John R. Mayo(Vancouver General Hospital), Ming‐Sound Tsao(Kumamoto University), Frances A. Shepherd(University Health Network), Heidi Schmidt(University Health Network), Stuart Peacock(BC Cancer Agency), Stefan J. Urbanski(University of Calgary), Ehsan Haider(St. Joseph’s Healthcare Hamilton), Sonya Cressman(BC Cancer Agency), Wan C. Tan(University of British Columbia), Garth Nicholas(Ottawa Regional Cancer Foundation), Scott Tsai(Juravinski Hospital), Geoffrey Liu(Princess Margaret Cancer Centre), Zhaolin Xu(Dalhousie University), Michel Gingras(Institut universitaire de cardiologie et de pneumologie de Québec), David Hwang(University Health Network), Diana N. Ionescu(BC Cancer Agency), Michael R. Johnston(Purdue University West Lafayette), John Yee(BC Cancer Agency), Colm Boylan(St. Joseph’s Healthcare Hamilton), Richard J. Finley(Vancouver General Hospital), Paul MacEachern(University of Calgary), Kam Soghrati(University Health Network), Sergio Pasian(Institut universitaire de cardiologie et de pneumologie de Québec), Sukhinder Atkar-Khattra(BC Cancer Agency)
Cited by 222
Related Papers
International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma
|Journal of Thoracic Oncology|2011|4.8k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2018|3.7k
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
|New England Journal of Medicine|2016|3.3k
Randomized Phase III Trial of Pemetrexed Versus Docetaxel in Patients With Non–Small-Cell Lung Cancer Previously Treated With Chemotherapy
|Journal of Clinical Oncology|2004|2.4k